Norges Bank’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-352,000
| Closed | -$5.54M | – | 2003 |
|
|
2024
Q1 | $5.54M | Hold |
352,000
| – | – | ﹤0.01% | 1598 |
|
|
2023
Q4 | $5.68M | Sell |
352,000
-68
| -0% | -$867 | ﹤0.01% | 1647 |
|
|
2023
Q3 | $4.48M | Hold |
352,068
| – | – | ﹤0.01% | 1699 |
|
|
2023
Q2 | $4.96M | Buy |
352,068
+65,000
| +23% | +$930K | ﹤0.01% | 1716 |
|
|
2023
Q1 | $4.44M | Buy |
+287,068
| New | +$4.79M | ﹤0.01% | 1794 |
|
|
2022
Q1 | – | Sell |
-368,042
| Closed | -$3.6M | – | 2250 |
|
|
2021
Q4 | $3.6M | Hold |
368,042
| – | – | ﹤0.01% | 1972 |
|
|
2021
Q3 | $12.5M | Sell |
368,042
-9,837
| -3% | -$314K | ﹤0.01% | 1696 |
|
|
2021
Q2 | $13.8M | Buy |
377,879
+53,011
| +16% | +$2.05M | ﹤0.01% | 1681 |
|
|
2021
Q1 | $14.6M | Sell |
324,868
-109,014
| -25% | -$5.08M | ﹤0.01% | 1663 |
|
|
2020
Q4 | $24.8M | Sell |
433,882
-10,978
| -2% | -$651K | 0.01% | 1435 |
|
|
2020
Q3 | $22.8M | Buy |
444,860
+56,781
| +15% | +$2.78M | 0.01% | 1334 |
|
|
2020
Q2 | $23.2M | Buy |
388,079
+208,724
| +116% | +$11.2M | 0.01% | 1347 |
|
|
2020
Q1 | $7.38M | Buy |
+179,355
| New | +$9.96M | ﹤0.01% | 1719 |
|
|
2019
Q1 | – | Sell |
-332,261
| Closed | -$6.97M | – | 2135 |
|
|
2018
Q4 | $6.97M | Sell |
332,261
-167,739
| -34% | -$4.12M | ﹤0.01% | 1852 |
|
|
2018
Q3 | $19.4M | Hold |
500,000
| – | – | 0.01% | 1548 |
|
|
2018
Q2 | $19.7M | Buy |
500,000
+425,000
| +567% | +$12.5M | 0.01% | 1541 |
|
|
2018
Q1 | $1.5M | Hold |
75,000
| – | – | ﹤0.01% | 2031 |
|
|
2017
Q4 | $1.7M | Hold |
75,000
| – | – | ﹤0.01% | 1995 |
|
|
2017
Q3 | $1.42M | Buy |
+75,000
| New | +$1.37M | ﹤0.01% | 2009 |
|
Other funds holding DCPH
Norges Bank's DCPH Position: Q2 2024 in Review
Norges Bank sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 352,000 shares — an estimated $5.54M sold.
Norges Bank first reported a position in DCPH in Q3 2017 and held it in 19 quarters. The position peaked at $24.8M in Q4 2020. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.
- Norges Bank reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
- Norges Bank sold 352,000 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $5.54M.
- Norges Bank first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2017 and held it in 19 quarters.
- Norges Bank's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $24.8M in Q4 2020.
- 1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.
Based on Norges Bank's 13F filing for Q2 2024, filed 14 Aug 2024.